FY/Q4 2015 Investor Conference Call
Thursday, February 25, 2016
Start at approx. 2:00 p.m. CET (1:00 p.m. UTC)
Fiscal 2015:
Another record year for Bayer
Focus on the Life Sciences following the successful stock market flotation of Covestro / Substantial sales and earnings increases at HealthCare / Good business development at CropScience despite a weaker market environment / Covestro posts strong earnings improvement / Group sales increase to EUR 46,324 million (plus 12.1 percent / Fx & portfolio adj. plus 2.7 percent) / EBITDA before special items advances by 18.2 percent to EUR 10,266 million / EBIT improves by 15.8 percent to EUR 6,250 million / Net income increases 20.0 percent to EUR 4,110 million / Core earnings per share up 16.0 percent to EUR 6.83 / Forecast for 2016: further growth in sales and earnings more
Audio recording of the Investor conference call
(MP3 format)
| Presentation charts | Download PDF collect (3 MB) |
| Annual Report 2015 | OnlineApp (for mobile devices)Download PDF collect (12 MB) |
| Q4 2015 Analyst and Investor Briefing | Download PDF collect (804 KB) |
| Transcript | Download PDF collect (362 KB) |
| FY/Q4 2015 All in One Package for Investors and Analysts All documents in one ZIP file | Download ZIP collect (16 MB) |
| Restatements 2014 / 2015 due to Covestro | Download XLSX collect (189 KB) |